Skip to main content
Premium Trial:

Request an Annual Quote

Agilent's Bid to Acquire Stratagene Tops Most-Read GenomeWeb News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, April 6.
 
1. Agilent to Buy Stratagene for $246M, CEO Sorge Plans Molecular Dx Spin-Off (from April 6)
 
2. Fraser-Liggett to Start New Genomics Institute at UMB Biopark (from April 5)
 
3. PerkinElmer Acquires Imaging Company Improvision to Expand HCS Business (from April 2)
 
4. Nanogen Lands GSA Contract, Opens Way for New Gov't Deals; Shares Surge 33 Percent (from April 4)
 
5. Roche, Swiss Non-profit Team to Study IVD Use in Developing Countries (from April 3)
The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.